更新時間:2022-01-27
The P84 monoclonal antibody reacts with Signal-Regulatory Protein α (SIRPα), also known as CD172a. SIRPα is a type I transmembrane glycoprotein expressed on monocytes, macrophages, and dendritic……
The P84 monoclonal antibody reacts with Signal-Regulatory Protein α (SIRPα), also known as CD172a. SIRPα is a type I transmembrane glycoprotein expressed on monocytes, macrophages, and dendritic cells. Neurons and other tissues of the central nervous system have also been shown to express SIRPα. Its ligand, CD47 is expressed by a wide variety of cells. SIRPα and CD47 regulate dendritic cell-mediated T cell activation, neutrophil migration, and phagocytosis. SIRPα diffuses laterally on the macrophage membrane and accumulates at a phagocytic synapse to bind CD47 which inhibits phagocytosis by macrophages. Anti-SIRPα antibodies that block the interaction of SIRPα with CD47 have been shown to suppress tumor formation in mice. The P84 antibody has been shown to have neutralizing activity in vivo and in vitro.
產品名稱:InVivoMAb anti-mouse CD172a (SIRPα)
反應種屬:mouse
宿主來源:Rat
實驗應用:in vivo SIRPα blocking, in vitro SIRPα blocking, Western blot, Immunoprecipitation, Flow cytometry
同種型:IgG1, κ
免疫原:Mouse brain membrane protein
克隆性:Monoclonal
克隆號:P84
產品濃度:Lot specific,typically between 4-11 mg/ml
保存溫度:Undiluted at 4°C in the dark
運輸溫度:Ship with adequate amount of blue ice to ensure the product remains at 4°C for the duration of transit
預期分子量:150 kDa
產品形式:液體
有效期:One year from the date of receipt if stored as recommended
產地:美國
如需購買或咨詢Bioxcell公司的產品,請聯系Bioxcell*代理商欣博盛生物